🔎 Trials Near Me

Início › Leucemia Mieloide Aguda › Tennessee › Memphis

Ensaios clínicos de Leucemia Mieloide Aguda em Memphis, TN

15 estudos para Leucemia Mieloide Aguda estão buscando participantes em locais em Memphis e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.

Texto oficial do estudo (Inglês)

Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RecrutandoFase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · a 12 mi de distância
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · a 23 mi de distância
Idades de 18 a 59 · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RecrutandoFase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · a 12 mi de distância
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · a 23 mi de distância
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05564390

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

RecrutandoFase 1
  • Saint Jude Children's Research Hospital, Memphis
Até 21 anos · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07012044

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RecrutandoFase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · a 12 mi de distância
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · a 23 mi de distância
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06317649

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RecrutandoFase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · a 12 mi de distância
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · a 23 mi de distância
Idades de 18 a 59 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT05554406

A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

RecrutandoFase 2
  • St. Jude Children's Research Hospital, Memphis
29 Days – 21 Years · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT05955261

A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

RecrutandoFase 1
  • St. Jude Children's Research Hospital, Memphis
Até 25 anos · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT06810583

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

RecrutandoFase 3
  • St. Jude Children's Research Hospital, Memphis
29 Days – 21 Years · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RecrutandoFase 3
  • Baptist Clinical Research Institute, Memphis
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT07007312

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

RecrutandoFase 1
  • Baptist Health Care Corporation, Memphis
Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT06399640

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

RecrutandoFase 1
  • St. Jude Children's Research Hospital, Memphis
Idades de 1 a 30 · Todos os sexos · Atualizado em 3 de ago. de 2026 · NCT06177067

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecrutandoEstudo observacional
  • St. Jude Childrens Research Hospital, Memphis
Todas as idades · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT01351545

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

RecrutandoFase 1
  • St. Jude Children's Research Hospital, Memphis
Até 21 anos · Todos os sexos · Atualizado em 22 de abr. de 2026 · NCT05101551

CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

RecrutandoFase 1
  • St. Jude Children's Research Hospital, Memphis
Até 21 anos · Todos os sexos · Atualizado em 23 de jan. de 2026 · NCT06326463

Ensaios de Leucemia Mieloide Aguda em outras cidades

Outros estudos em Memphis

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.